» Articles » PMID: 30850332

Intraoperative Brachytherapy for Resected Brain Metastases

Overview
Journal Brachytherapy
Specialty Radiology
Date 2019 Mar 10
PMID 30850332
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Brain metastases are the most common intracranial malignancies in adults. Surgical resection is the preferred treatment approach when a pathological diagnosis is required, for symptomatic patients who are refractory to steroids, and to decompress lesions causing mass effect. Radiotherapy is administered to improve local control rates after surgical resection. After a brief review of the literature describing the treatment of brain metastases using whole-brain radiotherapy, postoperative stereotactic radiosurgery, preoperative radiosurgery, and brachytherapy, we compare patient-related, technical, practical, and radiobiological considerations of each technique. Finally, we focus our discussion on intraoperative brachytherapy, with an emphasis on the technical aspects, benefits, efficacy, and outcomes of studies utilizing permanent Cs-131 implants.

Citing Articles

Laser hyperthermia: Past, present, and future.

Schupper A, Chanenchuk T, Racanelli A, Price G, Hadjipanayis C Neuro Oncol. 2022; 24(Suppl 6):S42-S51.

PMID: 36322099 PMC: 9629480. DOI: 10.1093/neuonc/noac208.


GammaTile: Comprehensive Review of a Novel Radioactive Intraoperative Seed-Loading Device for the Treatment of Brain Tumors.

Ekhator C, Nwankwo I, Rak E, Homayoonfar A, Fonkem E, Rak R Cureus. 2022; 14(10):e29970.

PMID: 36225241 PMC: 9541893. DOI: 10.7759/cureus.29970.


Patient-specific radiological protection precautions following Cs collagen embedded Cs-131 implantation in the brain.

Prasad K, Dauer L, Chu B, Aramburu-Nunez D, Cohen G, Beal K J Appl Clin Med Phys. 2022; 23(10):e13776.

PMID: 36109179 PMC: 9588267. DOI: 10.1002/acm2.13776.


Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.

Imber B, Young R, Beal K, Reiner A, Giantini-Larsen A, Krebs S J Neurooncol. 2022; 159(3):609-618.

PMID: 35896906 PMC: 9328626. DOI: 10.1007/s11060-022-04101-9.


The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.

Palmisciano P, Haider A, Balasubramanian K, DAmico R, Wernicke A J Neurooncol. 2022; 159(1):117-133.

PMID: 35696019 DOI: 10.1007/s11060-022-04050-3.